The immune system in cancer metastasis: Friend or foe?

Louise M.E. Janssen, Emma E. Ramsay, Craig D. Logsdon, Willem W. Overwijk

Research output: Contribution to journalReview articlepeer-review

172 Scopus citations

Abstract

Metastatic disease is the leading cause of death among cancer patients and involves a complex and inefficient process. Every step of the metastatic process can be rate limiting and is influenced by non-malignant host cells interacting with the tumor cell. Over a century ago, experiments first indicated a link between the immune system and metastasis. This phenomenon, called concomitant immunity, indicates that the primary tumor induces an immune response, which may not be sufficient to destroy the primary tumor, but prevents the growth of a secondary tumor or metastases. Since that time, many different immune cells have been shown to play a role in both inhibiting and promoting metastatic disease. Here we review classic and new observations, describing the links between the immune system and metastasis that inform the development of cancer therapies.

Original languageEnglish (US)
Article number79
JournalJournal for immunotherapy of cancer
Volume5
Issue number1
DOIs
StatePublished - Oct 17 2017

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Fingerprint

Dive into the research topics of 'The immune system in cancer metastasis: Friend or foe?'. Together they form a unique fingerprint.

Cite this